Listed by the USPTO as TRAN, KHOA NHAT
Tech Center 1600 • Art Units: 1632
This examiner grants 42% of resolved cases
TRAN, KHOA NHAT works in tech center 1600 and art unit 1632. The profile covers 93 resolved cases, with a 41.9% allowance rate and a 50.5% interview lift. The median time to allowance is 1552 days. The observed allowance measure is below an even outcome, while the substantial interview association supports detailed preparation for examiner discussions.
The principal companies are The Regents of the University of California, Memorial Sloan Kettering Cancer Center, and The Brigham and Women's Hospital Inc. The listed firms are BAKER BOTTS L.L.P., Clark+Elbing LLP, and FOLEY & LARDNER LLP. The participant mix places this profile in university and medical research prosecution.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18633827 | METHODS AND COMPOSITIONS FOR DELIVERY OF IMMUNOTHERAPY AGENTS ACROSS THE BLOOD-BRAIN BARRIER TO TREAT BRAIN CANCER | Non-Final OA | The Brigham and Women's Hospital, Inc. |
| 18684155 | ANTIGEN PRESENTING CELL/TARGET CELL HYBRIDOMA-DERIVED VACCINES | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 17921739 | Methods for Generating Thymic Cells in Vitro | Non-Final OA | The Regents of the University of California |
| 17839138 | MEDIA FOR CRYOPRESERVED CELLS AND METHODS OF MAKING AND USING SAME | Final Rejection | Washington University |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy41.9% of resolved applications examined by Khoa Nhat Tran were allowed (93 resolved cases), compared with 38.1% across Art Unit 1632 over the last five years.
This examiner's interview lift is +50.5 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Khoa Nhat Tran took 1,552 days on average from filing to allowance.
Khoa Nhat Tran examines applications in Art Unit 1632 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
